Table 6 Time trends of age-standardized mortality rates from common cancers among females in Serbia, 1991–2015, by joinpoint analysis
From: Cancer mortality in Serbia, 1991–2015: an age-period-cohort and joinpoint regression analysis
Cancer site | AAPC (95% CI) | Trend 1 | APC (95% CI) | Trend 2 | APC (95% CI) | Trend 3 | APC (95% CI) |
|---|---|---|---|---|---|---|---|
Lung | 3.7* (3.5 to 3.9) | 1991–2010 | 4.0* (3.7 to 4.3) | 2010–2015 | 1.9 (− 0.3 to 4.1) | None | – |
Breast | 0.3* (0.1 to 0.6) | 1991–2004 | 1.1* (0.6 to 1.6) | 2004–2015 | − 0.6* (− 1.2 to 0.0) | None | – |
Colon | 0.5* (0.2 to 0.9) | 1991–2009 | 1.1* (0.6 to 1.5) | 2009–2015 | − 2.0 (− 4.3 to 0.3) | None | – |
Stomach | − 2.0* (− 2.4 to − 1.6) | None | – | None | – | None | – |
Hematological malignancies | 0.6* (0.2 to 1.0) | None | – | None | – | None | – |
Cervix uteri | 0.1 (-0.3 to 0.5) | 1991–2008 | 0.9* (0.4 to 1.3) | 2008–2015 | − 2.7* (− 4.4 to − 0.9) | None | |
Ovary | 0.9* (0.6 to 1.3) | None | – | None | – | None | – |
Brain | 1.1* (0.4 to 1.8) | 1991–1995 | 8.5* (1.6 to 15.9) | 1995–2010 | 1.2* (0.2 to 2.2) | 2010–2015 | − 4.1 (− 8.5 to 0.4) |
Bladder | 0.9* (0.5 to 1.3) | None | – | None | – | None | – |
Pancreas | 1.9* (1.6 to 2.3) | None | – | None | – | None | – |
Renal | -0.4 (-0.9 to 0.2) | None | – | None | – | None | – |
All sites | 0.5* (0.4 to 0.7) | 1991–2009 | 0.8* (0.7 to 0.9) | 2009–2015 | − 0.9* (− 1.5 to − 0.4) | None | – |